結果ページ13 セクター：医療 産業：バイオテクノロジー 株式市場―見積もりと価格
価格、時価総額、PE、EPSを含む全株式と自己資本のリスト
すべての国
- {{country.name}}
- すべての国
- 米国 (1012)
- オーストラリア (57)
- オーストリア (16)
- ベルギー (7)
- ブラジル (16)
- カナダ (83)
- 中国 (93)
- デンマーク (6)
- フィンランド (4)
- フランス (41)
- ドイツ (739)
- 香港 (46)
- インド (19)
- アイルランド (1)
- イスラエル (19)
- イタリア (4)
- 日本 (37)
- メキシコ (28)
- オランダ (3)
- ニュージーランド (1)
- ノルウェー (15)
- ポーランド (9)
- ロシア (2)
- 韓国 (20)
- スペイン (4)
- スウェーデン (70)
- スイス (11)
- 台湾 (67)
- タイ (2)
- トルコ (1)
- イギリス (68)
全取引所
- {{item.name}}
- 全取引所
- Amsterdam (3)
- ASX (57)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KOSDAQ (10)
- KSE (10)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NSE (10)
- NYSE (11)
- NYSE American (18)
- NYSEArca (1)
- NZSE (1)
- Oslo (15)
- OTC Markets EXMKT (128)
- OTC Markets OTCPK (123)
- OTC Markets OTCQB (35)
- OTC Markets OTCQX (7)
- Other OTC (39)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (46)
- Stockholm (70)
- Stuttgart (39)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tech Market Large (212)
- Tech Market Middle (139)
- Tech Market Small (299)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (24)
バイオテクノロジー (2616)
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 |
|---|
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Savara Inc. YB4P.F | €3.68 4.02 USD |
-1.08
|
€740.79M 809.79M USD | €279.00 304.98 USD | €3.68 4.02 USD | €3.68 4.02 USD | €740.79M 809.79M USD | 0 | -€0.44 -0.4 USD | |
| Geron Corporation GON.F | €1.05 1.14 USD |
+4.33
|
€724.85M 792.36M USD | €1.50K 1.64K USD | €1.05 1.14 USD | €1.05 1.14 USD | €724.85M 792.36M USD | 0 | -€0.10 -0.1 USD | |
| Supriya Lifescience Limited SUPRIYA.NS | ₹762.40 9.22 USD |
+2.56
|
₹64.02B 774.56M USD | ₹280.72K 3.4K USD | ₹740.00 8.95 USD | ₹771.45 9.33 USD | ₹64.02B 774.56M USD | 34.41 | ₹22.15 0.27 USD | |
| Supriya Lifescience Limited SUPRIYA.BO | ₹761.45 9.21 USD |
+2.44
|
₹63.95B 773.65M USD | ₹5.92K 71.63 USD | ₹740.00 8.95 USD | ₹770.00 9.32 USD | ₹63.95B 773.65M USD | 34.37 | ₹22.15 0.27 USD | |
| Replimune Group, Inc. 7R8.F | €7.75 8.47 USD |
+6.9
|
€701.61M 766.96M USD | €200.00 218.63 USD | €7.75 8.47 USD | €7.75 8.47 USD | €701.61M 766.96M USD | 0 | -€3.00 -3.2 USD | |
| Valneva SE INRLF | $4.40 — |
-4.35
|
$756.07M — | $175.00 — | $4.40 — | $4.40 — | $756.07M — | 0 | -$0.53 — | |
| Valneva SE AYJ0.F | €7.10 7.76 USD |
-4.7
|
€661.52M 723.14M USD | €350.00 382.6 USD | €7.00 7.65 USD | €7.10 7.76 USD | €661.52M 723.14M USD | 0 | -€0.92 -1.005 USD | |
| Sunmax Biotechnology Co., Ltd. 4728.TWO | NT$398.00 12.65 USD |
+0.13
|
NT$21.68B 688.77M USD | NT$13.13K 417.27 USD | NT$398.00 12.65 USD | NT$402.00 12.77 USD | NT$21.68B 688.77M USD | 30.99 | NT$12.84 0.41 USD | |
| Anavex Life Sciences Corp. 12X1.F | €6.05 6.61 USD |
+4.21
|
€616.49M 673.91M USD | €424.00 463.49 USD | €5.79 6.33 USD | €6.05 6.61 USD | €616.49M 673.91M USD | 0 | -€0.49 -0.5 USD | |
| Takara Bio Inc. 4974.T | ¥822 5.55 USD |
-9.17
|
¥99B 668.15M USD | ¥797K 5.38K USD | ¥814 5.49 USD | ¥834 5.63 USD | ¥99B 668.15M USD | 0 | -¥53 -0.3 USD | |
| Inventiva IVEVF | $4.44 — |
0
|
$647.76M — | $600.00 — | $4.14 — | $4.50 — | $647.76M — | 0 | -$4.35 — | |
| REGENXBIO Inc. RB0.F | €9.95 10.88 USD |
+5.85
|
€590.08M 645.04M USD | €2.50K 2.73K USD | €9.95 10.88 USD | €9.95 10.88 USD | €590.08M 645.04M USD | 0 | -€2.99 -3.2 USD | |
| CytomX Therapeutics, Inc. 6C1.F | €3.48 3.8 USD |
+0.87
|
€589.30M 644.18M USD | €1.35K 1.48K USD | €3.48 3.8 USD | €3.48 3.8 USD | €589.30M 644.18M USD | 13.37 | €0.26 0.28 USD | |
| Gossamer Bio, Inc. 4GB.MU | €2.20 2.4 USD |
+4.97
|
€582.83M 637.11M USD | €0.00 0 USD | €2.20 2.4 USD | €2.20 2.4 USD | €582.83M 637.11M USD | 0 | -€0.79 -0.8 USD | |
| Takara Bio Inc. TF2.F | €4.36 4.77 USD |
-8.02
|
€574.02M 627.48M USD | €200.00 218.63 USD | €4.36 4.77 USD | €4.36 4.77 USD | €574.02M 627.48M USD | 87.20 | €0.05 0.05 USD | |
| Akebia Therapeutics, Inc. AX9.F | €1.61 1.76 USD |
+12.2
|
€568.15M 621.07M USD | €500.00 546.57 USD | €1.52 1.67 USD | €1.61 1.76 USD | €568.15M 621.07M USD | 0 | -€0.07 -0.07 USD | |
| Viva Biotech Holdings VB0.F | €0.23 0.26 USD |
-2.5
|
€558.24M 610.23M USD | €5.78K 6.32K USD | €0.23 0.26 USD | €0.23 0.26 USD | €558.24M 610.23M USD | 23.39 | €0.01 0.01 USD | |
| Opthea OPT | $3.41 — |
0
|
$583.10M — | $0.00 — | $3.41 — | $3.41 — | $583.10M — | 0 | -$2.25 — | |
| Viva Biotech Holdings VBIZF | $0.26 — |
0
|
$575.28M — | $100.00 — | $0.30 — | $0.30 — | $575.28M — | 26.35 | $0.01 — | |
| Dishman Carbogen Amcis Limited DCAL.BO | ₹256.45 3.1 USD |
+3.89
|
₹47.52B 574.92M USD | ₹16.24K 196.49 USD | ₹247.00 2.99 USD | ₹257.75 3.12 USD | ₹47.52B 574.92M USD | 29.44 | ₹8.71 0.11 USD | |
| Dishman Carbogen Amcis Limited DCAL.NS | ₹256.35 3.1 USD |
+3.87
|
₹47.51B 574.81M USD | ₹255.63K 3.09K USD | ₹246.00 2.98 USD | ₹257.95 3.12 USD | ₹47.51B 574.81M USD | 29.43 | ₹8.71 0.11 USD | |
| Green Cross Holdings Corporation 005250.KS | ₩16,650 12.57 USD |
+3.1
|
₩760B 573.67M USD | ₩204K 154.16 USD | ₩16,000 12.08 USD | ₩16,690 12.6 USD | ₩760B 573.67M USD | 0 | ₩0 0 USD | |
| Prestige BioPharma Limited 950210.KS | ₩12,630 9.53 USD |
+3.36
|
₩759B 572.93M USD | ₩146K 110.36 USD | ₩12,250 9.25 USD | ₩12,810 9.67 USD | ₩759B 572.93M USD | 0 | ₩0 0 USD | |
| Niagen Bioscience, Inc. OCD1.F | €5.90 6.45 USD |
+0.85
|
€524.12M 572.93M USD | €1.20K 1.31K USD | €5.90 6.45 USD | €5.90 6.45 USD | €524.12M 572.93M USD | 28.09 | €0.21 0.23 USD | |
| Inventiva S.A. 6IVA.F | €3.12 3.41 USD |
-0.64
|
€521.75M 570.34M USD | €275.00 300.61 USD | €3.12 3.41 USD | €3.12 3.41 USD | €521.75M 570.34M USD | 0 | -€3.76 -4.1 USD | |
| Green Cross Holdings Corporation 005257.KS | ₩25,100 18.95 USD |
+2.24
|
₩754B 568.91M USD | ₩615 0.46 USD | ₩24,700 18.64 USD | ₩25,500 19.25 USD | ₩754B 568.91M USD | 0 | ₩0 0 USD | |
| Zota Health Care Limited ZOTA.NS | ₹1,532.50 18.54 USD |
+1.56
|
₹46.55B 563.17M USD | ₹23.91K 289.28 USD | ₹1,506.80 18.23 USD | ₹1,553.90 18.8 USD | ₹46.55B 563.17M USD | 0 | -₹21.42 -0.2 USD | |
| Opthea Limited UKJ2.F | €3.00 3.28 USD |
0
|
€512.99M 560.77M USD | €0.00 0 USD | €3.00 3.28 USD | €3.00 3.28 USD | €512.99M 560.77M USD | 0 | -€1.94 -2.1 USD | |
| Gossamer Bio, Inc. 4GB.F | €2.14 2.34 USD |
+2.68
|
€511.82M 559.49M USD | €100.00 109.31 USD | €2.14 2.34 USD | €2.14 2.34 USD | €511.82M 559.49M USD | 0 | -€0.60 -0.6 USD | |
| Prothena Corporation plc 0PT.F | €8.95 9.78 USD |
0
|
€511.52M 559.16M USD | €24.00 26.24 USD | €8.95 9.78 USD | €8.95 9.78 USD | €511.52M 559.16M USD | 0 | -€4.50 -4.9 USD | |
| Inventiva S.A. 6IV.F | €3.16 3.45 USD |
-2.92
|
€509.75M 557.22M USD | €500.00 546.57 USD | €3.16 3.45 USD | €3.16 3.45 USD | €509.75M 557.22M USD | 0 | -€3.76 -4.1 USD | |
| Zevra Therapeutics, Inc. 1GDA.F | €8.05 8.8 USD |
+3.21
|
€509.68M 557.15M USD | €10.00 10.93 USD | €8.05 8.8 USD | €8.05 8.8 USD | €509.68M 557.15M USD | 19.63 | €0.41 0.45 USD | |
| KalVista Pharmaceuticals, Inc. 4XC1.F | €9.70 10.6 USD |
-3
|
€502.24M 549.02M USD | €930.00 1.02K USD | €9.70 10.6 USD | €9.70 10.6 USD | €502.24M 549.02M USD | 0 | -€3.41 -3.7 USD | |
| Opthea Limited OPT.AX | A$0.60 0.4 USD |
0
|
A$820.79M 543.24M USD | A$6.21M 4.11M USD | A$0.60 0.39 USD | A$0.62 0.41 USD | A$820.79M 543.24M USD | 0 | -A$0.43 -0.2 USD | |
| NovaBridge Biosciences 0VY.F | €3.58 3.91 USD |
-0.56
|
€490.34M 536.01M USD | €4.45K 4.86K USD | €3.58 3.91 USD | €3.58 3.91 USD | €490.34M 536.01M USD | 0 | -€0.44 -0.4 USD | |
| NovaBridge Biosciences IMAB | $4.63 — |
0
|
$533.68M — | $0.00 — | $0.00 — | $0.00 — | $533.68M — | 0 | $0.00 — | |
| Bicycle Therapeutics plc 50BA.F | €5.70 6.23 USD |
+0.88
|
€488.06M 533.51M USD | €315.00 344.34 USD | €5.70 6.23 USD | €5.70 6.23 USD | €488.06M 533.51M USD | 0 | -€3.13 -3.4 USD | |
| Omeros Corporation 3O8.F | €6.50 7.11 USD |
+10.17
|
€474.95M 519.18M USD | €1.08K 1.18K USD | €6.50 7.11 USD | €6.50 7.11 USD | €474.95M 519.18M USD | 0 | -€2.04 -2.2 USD | |
| DBV Technologies S.A. DBV.F | €2.53 2.77 USD |
+6.98
|
€474.45M 518.63M USD | €400.00 437.25 USD | €2.53 2.77 USD | €2.53 2.77 USD | €474.45M 518.63M USD | 0 | -€0.90 -0.9 USD | |
| Nxera Pharma Co., Ltd. JSS.F | €4.54 4.96 USD |
+2.71
|
€467.63M 511.18M USD | €400.00 437.25 USD | €4.54 4.96 USD | €4.54 4.96 USD | €467.63M 511.18M USD | 0 | -€0.20 -0.2 USD | |
| Nxera Pharma SOLTF | $5.50 — |
0
|
$497.72M — | $100.00 — | $6.40 — | $6.40 — | $497.72M — | 0 | -$0.23 — | |
| Altimmune, Inc. ALT1.MX | MX$78.70 4.66 USD |
0
|
MX$8.21B 486.24M USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$8.21B 486.24M USD | 0 | -MX$19.67 -1.1 USD | |
| Opthea Limited UKJ.F | €0.32 0.35 USD |
0
|
€437.75M 478.52M USD | €7.00K 7.65K USD | €0.32 0.35 USD | €0.32 0.35 USD | €437.75M 478.52M USD | 0 | -€0.25 -0.2 USD | |
| Avacta AVCTF | $1.05 — |
0
|
$455.35M — | $26.00K — | $0.96 — | $1.05 — | $455.35M — | 0 | -$0.15 — | |
| Ocugen, Inc. OCGN.MX | MX$24.00 1.42 USD |
0
|
MX$7.64B 452.23M USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$7.64B 452.23M USD | 0 | -MX$4.06 -0.2 USD | |
| Autolus Therapeutics plc 6A3A.F | €1.32 1.44 USD |
+14.78
|
€409.20M 447.31M USD | €1.00K 1.09K USD | €1.32 1.44 USD | €1.32 1.44 USD | €409.20M 447.31M USD | 0 | -€0.75 -0.8 USD | |
| Bright Minds Biosciences Inc. DRUG.CN | CA$81.24 60.28 USD |
-2.37
|
CA$575.88M 427.34M USD | CA$0.00 0 USD | CA$0.00 0 USD | CA$0.00 0 USD | CA$575.88M 427.34M USD | 0 | -CA$1.37 -1.01 USD | |
| Formycon AG FYB.F | €21.55 23.56 USD |
+0.94
|
€390.47M 426.84M USD | €345.00 377.13 USD | €21.55 23.56 USD | €21.55 23.56 USD | €390.47M 426.84M USD | 0 | -€9.67 -10.5 USD | |
| PureTech Health PTCHF | $1.68 — |
0
|
$406.03M — | $1.00K — | $1.70 — | $1.70 — | $406.03M — | 9.88 | $0.17 — | |
| PureTech Health plc 0VQ0.F | €13.10 14.32 USD |
+0.77
|
€365.56M 399.61M USD | €0.00 0 USD | €13.10 14.32 USD | €13.10 14.32 USD | €365.56M 399.61M USD | 8.91 | €1.47 1.61 USD | |
| PureTech Health PRTC | $16.34 — |
-6.63
|
$394.91M — | $29.92K — | $16.22 — | $17.50 — | $394.91M — | 9.61 | $1.70 — | |
| XOMA Royalty Corporation X0M1.F | €29.40 32.14 USD |
+4.26
|
€359.18M 392.63M USD | €13.00 14.21 USD | €29.40 32.14 USD | €29.40 32.14 USD | €359.18M 392.63M USD | 0 | -€1.23 -1.3 USD | |
| Oncoinvent ASA BRRGF | $2.50 — |
0
|
$391.60M — | $37.31K — | $0.03 — | $0.03 — | $391.60M — | 0 | -$5.26 — | |
| Rocket Pharmaceuticals, Inc. 9IP1.F | €2.53 2.77 USD |
+0.28
|
€352.53M 385.36M USD | €7.90K 8.64K USD | €2.53 2.77 USD | €2.53 2.77 USD | €352.53M 385.36M USD | 0 | -€1.95 -2.1 USD | |
| Antengene Corporation Limited 722.F | €0.51 0.56 USD |
0
|
€351.99M 384.77M USD | €103.00 112.59 USD | €0.51 0.56 USD | €0.51 0.56 USD | €351.99M 384.77M USD | 0 | -€0.04 -0.04 USD | |
| Avacta Group Plc RTQ1.F | €0.81 0.89 USD |
-1.82
|
€351.27M 383.98M USD | €6.00K 6.56K USD | €0.81 0.89 USD | €0.81 0.89 USD | €351.27M 383.98M USD | 0 | -€0.13 -0.1 USD | |
| Clinuvel Pharmaceuticals CLVLF | $7.56 — |
0
|
$379.52M — | $100.00 — | $7.56 — | $7.56 — | $379.52M — | 16.08 | $0.47 — | |
| Healios K.K. 6VX.F | €2.48 2.71 USD |
+8.77
|
€346.81M 379.11M USD | €350.00 382.6 USD | €2.48 2.71 USD | €2.48 2.71 USD | €346.81M 379.11M USD | 0 | -€0.34 -0.3 USD | |
| Cellectis S.A. CMVLF | $5.04 — |
0
|
$371.73M — | $100.00 — | $4.26 — | $4.26 — | $371.73M — | 0 | -$0.33 — | |
| Altimmune, Inc. 3G0.F | €3.59 3.92 USD |
-4.85
|
€339.89M 371.54M USD | €800.00 874.51 USD | €3.59 3.92 USD | €3.59 3.92 USD | €339.89M 371.54M USD | 0 | -€0.93 -1.01 USD | |
| Galectin Therapeutics Inc. PHPN.F | €4.70 5.14 USD |
+3.07
|
€333.69M 364.77M USD | €2.00K 2.19K USD | €4.70 5.14 USD | €4.70 5.14 USD | €333.69M 364.77M USD | 0 | -€0.55 -0.6 USD | |
| Newron Pharmaceuticals S.p.A. NP5.F | €16.00 17.49 USD |
+6.1
|
€329.69M 360.39M USD | €14.40K 15.74K USD | €15.20 16.62 USD | €16.00 17.49 USD | €329.69M 360.39M USD | 11.76 | €1.36 1.49 USD | |
| Cellectis S.A. ZVAA.F | €3.14 3.43 USD |
+6.08
|
€328.32M 358.9M USD | €1.86K 2.03K USD | €3.14 3.43 USD | €3.14 3.43 USD | €328.32M 358.9M USD | 0 | -€0.28 -0.3 USD | |
| Flerie AB (publ) 1NP.F | €4.16 4.55 USD |
+1.96
|
€325.60M 355.93M USD | €1.00 1.09 USD | €4.03 4.41 USD | €4.14 4.53 USD | €325.60M 355.93M USD | 0 | -€8.83 -9.6 USD | |
| Cellectis S.A. ZVA.F | €3.16 3.45 USD |
+4.99
|
€324.95M 355.22M USD | €1.25K 1.37K USD | €3.16 3.45 USD | €3.16 3.45 USD | €324.95M 355.22M USD | 0 | -€0.28 -0.3 USD | |
| Clinuvel Pharmaceuticals Limited UR9A.F | €5.95 6.5 USD |
-0.83
|
€324.51M 354.73M USD | €1.68K 1.84K USD | €5.95 6.5 USD | €5.95 6.5 USD | €324.51M 354.73M USD | 14.51 | €0.41 0.45 USD | |
| Clinuvel Pharmaceuticals Limited UR9.F | €6.00 6.56 USD |
-2.91
|
€317.70M 347.29M USD | €1.02K 1.11K USD | €6.00 6.56 USD | €6.00 6.56 USD | €317.70M 347.29M USD | 14.63 | €0.41 0.45 USD | |
| Gongwin Biopharm Holdings Co., Ltd. 6617.TWO | NT$86.40 2.75 USD |
-4
|
NT$10.59B 336.64M USD | NT$174.15K 5.53K USD | NT$86.40 2.75 USD | NT$90.20 2.87 USD | NT$10.59B 336.64M USD | 0 | -NT$0.48 -0.01 USD | |
| Panacea Biotec Limited PANACEABIO.NS | ₹400.55 4.85 USD |
+0.98
|
₹27.08B 327.58M USD | ₹88.77K 1.07K USD | ₹393.05 4.76 USD | ₹404.50 4.89 USD | ₹27.08B 327.58M USD | 215.34 | ₹1.86 0.02 USD | |
| Panacea Biotec Limited PANACEABIO.BO | ₹399.55 4.83 USD |
+0.79
|
₹27.03B 326.96M USD | ₹4.35K 52.58 USD | ₹395.00 4.78 USD | ₹407.05 4.92 USD | ₹27.03B 326.96M USD | 214.81 | ₹1.86 0.02 USD | |
| Larimar Therapeutics, Inc. ZA71.F | €3.10 3.39 USD |
+2.65
|
€295.35M 322.86M USD | €510.00 557.5 USD | €3.10 3.39 USD | €3.10 3.39 USD | €295.35M 322.86M USD | 0 | -€1.70 -1.8 USD | |
| Enanta Pharmaceuticals, Inc. 9EP.F | €10.20 11.15 USD |
-0.97
|
€294.30M 321.71M USD | €54.00 59.03 USD | €10.20 11.15 USD | €10.20 11.15 USD | €294.30M 321.71M USD | 0 | -€3.74 -4.08 USD | |
| AC Immune SA IMR.F | €2.85 3.12 USD |
-4.68
|
€286.71M 313.41M USD | €2.00K 2.19K USD | €2.85 3.12 USD | €2.85 3.12 USD | €286.71M 313.41M USD | 0 | -€0.77 -0.8 USD | |
| Silence Therapeutics plc XRP2.F | €6.05 6.61 USD |
+15.24
|
€285.77M 312.38M USD | €827.00 904.02 USD | €5.55 6.07 USD | €6.05 6.61 USD | €285.77M 312.38M USD | 0 | -€1.17 -1.2 USD | |
| Oryzon Genomics S.A. ORN.F | €2.89 3.16 USD |
+1.76
|
€284.05M 310.51M USD | €50.00 54.66 USD | €2.89 3.16 USD | €2.89 3.16 USD | €284.05M 310.51M USD | 0 | -€0.06 -0.06 USD | |
| Avalo Therapeutics Inc. R C6K0.F | €13.20 14.43 USD |
+1.85
|
€282.49M 308.8M USD | €4.00 4.37 USD | €13.20 14.43 USD | €13.20 14.43 USD | €282.49M 308.8M USD | 0 | -€11.60 -12.6 USD | |
| Frontage FGHQF | $0.15 — |
0
|
$303.75M — | $130.00 — | $0.15 — | $0.15 — | $303.75M — | 0 | $0.00 — | |
| Immutep PRRUF | $0.20 — |
0
|
$294.38M — | $2.50K — | $0.22 — | $0.22 — | $294.38M — | 0 | -$0.03 — | |
| Aldeyra Therapeutics, Inc. 137.F | €4.46 4.87 USD |
-1.07
|
€268.03M 292.99M USD | €520.00 568.43 USD | €4.46 4.87 USD | €4.46 4.87 USD | €268.03M 292.99M USD | 0 | -€0.63 -0.6 USD | |
| Astria Therapeutics, Inc. 2090.MU | €4.74 5.18 USD |
0
|
€267.40M 292.3M USD | €108.00 118.06 USD | €4.74 5.18 USD | €4.74 5.18 USD | €267.40M 292.3M USD | 0 | -€44.71 -48.8 USD | |
| Hansa Biopharma AB (publ) HNSBF | $2.91 — |
0
|
$290.20M — | $150.00 — | $2.93 — | $2.93 — | $290.20M — | 0 | -$0.95 — | |
| scPharmaceuticals Inc. 2SX.F | €4.76 5.2 USD |
0
|
€261.18M 285.51M USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €261.18M 285.51M USD | 0 | €0.00 0 USD | |
| Oryzon Genomics ORYZF | $3.61 — |
0
|
$284.66M — | $5.00K — | $3.03 — | $3.03 — | $284.66M — | 0 | -$0.07 — | |
| Capricor Therapeutics, Inc. 4LN2.F | €5.17 5.65 USD |
+4.97
|
€257.70M 281.7M USD | €200.00 218.63 USD | €5.17 5.65 USD | €5.17 5.65 USD | €257.70M 281.7M USD | 0 | -€1.51 -1.6 USD | |
| Editas Medicine, Inc. 8EM.F | €2.32 2.54 USD |
+6.36
|
€254.58M 278.29M USD | €500.00 546.57 USD | €2.32 2.54 USD | €2.32 2.54 USD | €254.58M 278.29M USD | 0 | -€2.03 -2.2 USD | |
| Vicore Pharma Holding AB (publ) 6Y4.F | €0.92 1 USD |
+3.74
|
€252.62M 276.15M USD | €1.00K 1.09K USD | €0.92 1 USD | €0.92 1 USD | €252.62M 276.15M USD | 0 | -€0.18 -0.1 USD | |
| Mereo BioPharma Group plc MAH0.F | €1.58 1.73 USD |
+7.12
|
€251.37M 274.78M USD | €600.00 655.88 USD | €1.58 1.73 USD | €1.58 1.73 USD | €251.37M 274.78M USD | 0 | -€0.26 -0.2 USD | |
| ProQR Therapeutics N.V. 0PQ.F | €1.82 1.98 USD |
0
|
€250.36M 273.67M USD | €758.00 828.6 USD | €1.82 1.98 USD | €1.82 1.98 USD | €250.36M 273.67M USD | 0 | -€0.41 -0.4 USD | |
| Mereo BioPharma Group plc MAH0.SG | €1.56 1.7 USD |
-3.72
|
€247.40M 270.44M USD | €0.00 0 USD | €1.56 1.7 USD | €1.56 1.71 USD | €247.40M 270.44M USD | 0 | -€0.26 -0.2 USD | |
| Atrys Health, S.A. A2T.F | €2.75 3.01 USD |
+1.48
|
€243.40M 266.07M USD | €1.03K 1.12K USD | €2.54 2.78 USD | €2.75 3.01 USD | €243.40M 266.07M USD | 0 | -€0.32 -0.3 USD | |
| Onward Medical N.V. 63E.F | €4.10 4.48 USD |
+1.11
|
€242.38M 264.95M USD | €140.00 153.04 USD | €3.98 4.35 USD | €4.10 4.48 USD | €242.38M 264.95M USD | 0 | -€0.74 -0.8 USD | |
| Egetis Therapeutics AB (publ) P0F.F | €0.53 0.58 USD |
+0.75
|
€242.28M 264.85M USD | €20.00K 21.86K USD | €0.53 0.58 USD | €0.53 0.58 USD | €242.28M 264.85M USD | 0 | -€0.09 -0.09 USD | |
| Immutep Limited YP1B.F | €0.13 0.15 USD |
+3.08
|
€240.80M 263.23M USD | €49.57K 54.19K USD | €0.13 0.15 USD | €0.13 0.15 USD | €240.80M 263.23M USD | 0 | -€0.02 -0.02 USD | |
| Egetis Therapeutics AB (publ) P0F.SG | €0.56 0.61 USD |
0
|
€240.47M 262.86M USD | €0.00 0 USD | €0.56 0.61 USD | €0.56 0.61 USD | €240.47M 262.86M USD | 0 | -€0.09 -0.09 USD | |
| Immutep Limited YP1A.F | €1.50 1.64 USD |
+2.74
|
€240.01M 262.37M USD | €1.70K 1.86K USD | €1.50 1.64 USD | €1.50 1.64 USD | €240.01M 262.37M USD | 0 | -€0.22 -0.2 USD | |
| Achieve Life Sciences, Inc. SP4P.F | €4.04 4.42 USD |
+5.62
|
€238.83M 261.08M USD | €2.29K 2.5K USD | €4.04 4.42 USD | €4.04 4.42 USD | €238.83M 261.08M USD | 0 | -€1.17 -1.2 USD | |
| Voyager Therapeutics, Inc. VYGR.MX | MX$78.50 4.65 USD |
-0.63
|
MX$4.36B 258.44M USD | MX$14.94K 884.63 USD | MX$78.50 4.65 USD | MX$79.20 4.69 USD | MX$4.36B 258.44M USD | 0 | -MX$39.89 -2.3 USD | |
| Hansa Biopharma AB (publ) 24H.F | €2.31 2.52 USD |
-0.69
|
€234.61M 256.46M USD | €517.00 565.15 USD | €2.31 2.52 USD | €2.31 2.52 USD | €234.61M 256.46M USD | 0 | -€0.83 -0.9 USD | |
| SELLAS Life Sciences Group, Inc. RXK3.F | €1.29 1.41 USD |
-0.77
|
€230.12M 251.55M USD | €6.12K 6.69K USD | €1.29 1.41 USD | €1.29 1.41 USD | €230.12M 251.55M USD | 0 | -€0.26 -0.2 USD | |
| Voyager Therapeutics, Inc. VT6.F | €3.52 3.84 USD |
+0.23
|
€224.37M 245.27M USD | €1.88K 2.05K USD | €3.52 3.84 USD | €3.52 3.84 USD | €224.37M 245.27M USD | 0 | -€1.88 -2.05 USD | |
|
お気に入り銘柄なし
お気に入りの株式はまだありません。ここで表示するにはお気に入りに追加してください |
||||||||||